Delayed Cord Clamping and Infant Brain Study (IBS)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01620008 |
|
Recruitment Status : Unknown
Verified October 2018 by Judith S Mercer, University of Rhode Island.
Recruitment status was: Active, not recruiting
First Posted : June 15, 2012
Last Update Posted : October 11, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Iron Deficiency | Procedure: Delayed Cord Clamping | Not Applicable |
The current obstetrical practice at birth in the United States is that the umbilical cord of the infant is clamped immediately. When immediate clamping occurs, 20 to 40% of the fetal-placental blood volume is left behind in the placenta. This blood contains enough iron-rich red blood cells to meet the infant's iron needs for the first 4 to 6 months of life. Delaying cord clamping has been shown to increase early iron stores without contributing to adverse outcomes. Early iron sufficiency is essential for long term neurologic health. Iron deficiency in infancy adversely affects cognitive, motor, socio-emotional, and behavioral development. Human and animal studies have shown that inadequate iron stores in early infancy have an irreversible negative impact on the developing brain with deficits persisting even after iron levels have been restored by iron supplementation. Iron is an essential component of myelination which is critical for normal brain development and function. Myelination, which peaks during the first year of life, establishes and maintains efficient communication between the discrete regions of the brain. Abnormal myelination underlies a variety of childhood developmental disorders including conditions such as autism.
The gap is that the effect of increased iron stores from delayed cord clamping on myelination and neurodevelopment during early childhood is unknown. Our hypothesis is that placental transfusion affects myelination and early childhood development in the following ways: 1) placental transfusions lead to increased blood volume (BV) and red cell volume (RCV) at birth; 2) increased RCV results in more available iron for early body iron stores; 3) increased body iron stores provide essential iron supply for optimal myelination; 4) optimal myelination results in improved developmental and cognitive performance. We propose a randomized controlled longitudinal (birth to 24 months) trial of 128 infants to measure the effect of placental transfusion on the structure and function of the developing brain. We will use a non-invasive neuroimaging technique to measure myelin acquisition over time and to correlate the findings with iron stores and developmental outcomes. Enrolled women will be randomized at birth to the immediate cord clamping group or the delayed cord clamping group. We will assess infants for iron sufficiency and myelin deposition at 4 and 10 months and evaluate developmental outcomes at 4, 10, and 24 months. This study will help to establish a scientific basis for the timing of cord clamping with reference to brain development. The innovation of this study is in the simplicity of delaying cord clamping combined with the use of a new method of MRI that can quantify myelin deposition. This low-tech change in a clinical practice has the potential to reduce iron deficiency and improve developmental outcomes. If delayed cord clamping demonstrates protective effects for optimal development, changing practice will translate into a large cost savings improving lifetime productivity beneficial to society as a whole.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 106 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | randomized trial (with a preference arm) |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Prevention |
| Official Title: | Effects of Placental Transfusion on Early Brain Development |
| Actual Study Start Date : | October 1, 2012 |
| Estimated Primary Completion Date : | December 31, 2018 |
| Estimated Study Completion Date : | December 31, 2018 |
| Arm | Intervention/treatment |
|---|---|
|
No Intervention: Immediate Cord Clamping (ICC)
The infant will be placed on the maternal abdomen and the umbilical cord will be clamped immediately after birth (routine care).
|
|
|
Experimental: Delayed Cord Clamping (DCC)
At birth, infants will be placed on the maternal abdomen and the cord clamping will be delayed for 5 minutes. If the provider is unable to delay the cord clamping, the cord will be milked 5 times.
|
Procedure: Delayed Cord Clamping
At birth, the infant will be placed on the maternal abdomen and the umbilical will either be cut immediately or after a 5 minute delay.
Other Name: delayed umbilical cord clamping |
- Brain Myelin Volume [ Time Frame: 4 months of age ]At 4 months of age, term infants exposed to delayed cord clamping will have greater myelin content when compared to infants exposed to immediate cord clamping
- Ferritin levels [ Time Frame: 4 months of age ]Term infants exposed to delayed cord clamping will have higher ferritin levels when compared to infants with immediate cord clamping.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 45 Years (Adult) |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- women in the third trimester with:
- singleton pregnancy
- planning to breastfeed for six months
- English speaking
- planning vaginal birth
Exclusion Criteria:
- major medical or obstetrical complications
- Intrauterine growth restriction
- chorioamnionitis
- familial learning disability
- major psychiatric or depressive illness
- fetal congenital anomalies
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01620008
| United States, Rhode Island | |
| Women & Infants Hospital of Rhode Island | |
| Providence, Rhode Island, United States, 02905 | |
| Principal Investigator: | Judith S Mercer, PhD, CNM | Women & Infants Hospital of Rhode Island, University of Rhode Island | |
| Principal Investigator: | Debra A Erickson-Owens, PhD, CNM | University of Rhode Island; Women & Infants Hospital of Rhode Island | |
| Principal Investigator: | Sean C. Deoni, PhD | Brown University |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Judith S Mercer, Principal Investigator, University of Rhode Island |
| ClinicalTrials.gov Identifier: | NCT01620008 |
| Other Study ID Numbers: |
Mercer-9329 |
| First Posted: | June 15, 2012 Key Record Dates |
| Last Update Posted: | October 11, 2018 |
| Last Verified: | October 2018 |
|
cord clamping (delayed or immediate) Myelin content Ferritin |
|
Anemia, Iron-Deficiency Anemia, Hypochromic Anemia |
Hematologic Diseases Iron Metabolism Disorders Metabolic Diseases |